Control of cell cycle progression in human mesothelioma cells treated with gamma interferon.

Oncogene 2001 Mar 1;20(9):1085-93
Vivo C, Levy F, Pilatte Y, Fleury-Feith J, Chretien P, Monnet I, Kheuang L, Jaurand MC.
INSERM E 99.09, Universite Paris Val de Marne Paris XII (EA 2345), Faculte de Medecine, 8 rue du General Sarrail, 94010, Creteil Cedex, France.

Recombinant human interferon gamma (r-hu-IFNgamma) exerts both antitumoral activity in the early stages of human malignant mesothelioma and a cytostatic effect in human mesothelioma (HM) cell lines in vitro. The antiproliferative effect of interferons (IFNs) reported in a variety of cells has been attributed to several mechanisms. In order to progress in the understanding of HM cell growth modulation by r-hu-IFNgamma, modifications of cell cycle progression and expression of key cell cycle regulator proteins in response to r-hu-IFNgamma were examined. Nine HM cell lines were studied, including one resistant to the antiproliferative effect of r-hu-IFNgamma. Except in the resistant cell line r-hu-IFNgamma produced an arrest in the G1 and G2-M phases of the cell cycle, associated with a reduction in both cyclin A and cyclin dependent kinase inhibitors (CDKIs) expression. Moreover cyclin B1/cdc2 activity was decreased. The present study provides the first evidence of a G2-arrest in r-hu-IFNgamma-treated HM cell lines and indicates that HM cell lines, despite their tumorigenic origin still support cell cycle control. The cell cycle arrest induced by r-hu-IFNgamma seems to depend on cyclin regulation through p21(WAF1/CIP1)- and p27(Kip1)-independent mechanisms and is not directly related to the induced DNA damage.

Source

PMID: 11314045 [PubMed - indexed for MEDLINE]
Click here to order or save article

If you have any questions regarding treatment options or your legal rights, please contact us.

If you have any questions regarding your legal rights, please contact us.
New York Office  360 Lexington Ave., 20th Floor  New York, New York, 10017  (P): 212-986-2233  (F): 212-986-2255
New Haven Office  One Century Tower, 265 Church Street  New Haven, CT 06508-1866  (P): 203-777-7799  (F): 203-785-1671

Copyright © 2010 by James F. Early LLC. All Rights Reserved. Attorney Advertising.

Thank you for visiting this website which is created for the benefit of the general public. This website and its content are produced and sponsored by the law firm of James F. Early, LLC (James F. Early, Esq.). This website is devoted to the needs of people diagnosed with mesothelioma; nonetheless it may be considered attorney advertising. The content contained herein was not prepared by medical professionals and it is not intended, nor should it be considered, as a substitute for medical advice. The information provided on this website is intended as educational material, designed solely to support, and not replace, the relationship that exists between a patient/site visitor and his/her healthcare professional. Additionally, neither visiting this website nor viewing its content is intended, and shall not be considered, to create an attorney-client relationship. An attorney-client relationship can only be created by mutual agreement and consent of the prospective client and the attorney. Neither the transmission nor receipt of this website material will create an attorney-client relationship between sender and receiver. The material contained herein is general in nature and may not apply to your particular factual or legal circumstances. Online readers should not act on this information without seeking professional counsel and advice. Please read our disclaimer for more information.